Literature DB >> 11012662

Thioredoxin reductase two modes of catalysis have evolved.

C H Williams1, L D Arscott, S Müller, B W Lennon, M L Ludwig, P F Wang, D M Veine, K Becker, R H Schirmer.   

Abstract

Thioredoxin reductase (EC 1.6.4.5) is a widely distributed flavoprotein that catalyzes the NADPH-dependent reduction of thioredoxin. Thioredoxin plays several key roles in maintaining the redox environment of the cell. Like all members of the enzyme family that includes lipoamide dehydrogenase, glutathione reductase and mercuric reductase, thioredoxin reductase contains a redox active disulfide adjacent to the flavin ring. Evolution has produced two forms of thioredoxin reductase, a protein in prokaryotes, archaea and lower eukaryotes having a Mr of 35 000, and a protein in higher eukaryotes having a Mr of 55 000. Reducing equivalents are transferred from the apolar flavin binding site to the protein substrate by distinct mechanisms in the two forms of thioredoxin reductase. In the low Mr enzyme, interconversion between two conformations occurs twice in each catalytic cycle. After reduction of the disulfide by the flavin, the pyridine nucleotide domain must rotate with respect to the flavin domain in order to expose the nascent dithiol for reaction with thioredoxin; this motion repositions the pyridine ring adjacent to the flavin ring. In the high Mr enzyme, a third redox active group shuttles the reducing equivalent from the apolar active site to the protein surface. This group is a second redox active disulfide in thioredoxin reductase from Plasmodium falciparum and a selenenylsulfide in the mammalian enzyme. P. falciparum is the major causative agent of malaria and it is hoped that the chemical difference between the two high Mr forms may be exploited for drug design.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11012662     DOI: 10.1046/j.1432-1327.2000.01702.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  75 in total

1.  Investigations of the catalytic mechanism of thioredoxin glutathione reductase from Schistosoma mansoni.

Authors:  Hsin-Hung Huang; Latasha Day; Cynthia L Cass; David P Ballou; Charles H Williams; David L Williams
Journal:  Biochemistry       Date:  2011-06-10       Impact factor: 3.162

2.  Non-animal origin of animal thioredoxin reductases: implications for selenocysteine evolution and evolution of protein function through carboxy-terminal extensions.

Authors:  Sergey V Novoselov; Vadim N Gladyshev
Journal:  Protein Sci       Date:  2003-02       Impact factor: 6.725

3.  X-ray structures of thioredoxin and thioredoxin reductase from Entamoeba histolytica and prevailing hypothesis of the mechanism of Auranofin action.

Authors:  Derek Parsonage; Fang Sheng; Ken Hirata; Anjan Debnath; James H McKerrow; Sharon L Reed; Ruben Abagyan; Leslie B Poole; Larissa M Podust
Journal:  J Struct Biol       Date:  2016-02-12       Impact factor: 2.867

Review 4.  Redox interactome in malaria parasite Plasmodium falciparum.

Authors:  Savitri Tiwari; Nivedita Sharma; Guru Prasad Sharma; Neelima Mishra
Journal:  Parasitol Res       Date:  2021-01-18       Impact factor: 2.289

5.  Cytosolic, mitochondrial thioredoxins and thioredoxin reductases in Arabidopsis thaliana.

Authors:  Claire Bréhélin; Christophe Laloi; Aaron T Setterdahl; David B Knaff; Yves Meyer
Journal:  Photosynth Res       Date:  2004       Impact factor: 3.573

6.  Ferredoxin:thioredoxin Reductase: Disulfide Reduction Catalyzed via Novel Site-specific [4Fe-4S] Cluster Chemistry.

Authors:  Elizabeth M Walters; Michael K Johnson
Journal:  Photosynth Res       Date:  2004       Impact factor: 3.573

7.  An arsenical-maleimide for the generation of new targeted biochemical reagents.

Authors:  Aparna Sapra; Colin Thorpe
Journal:  J Am Chem Soc       Date:  2013-02-08       Impact factor: 15.419

8.  The CXC motif: a functional mimic of protein disulfide isomerase.

Authors:  Kenneth J Woycechowsky; Ronald T Raines
Journal:  Biochemistry       Date:  2003-05-13       Impact factor: 3.162

9.  Solution structures of Mycobacterium tuberculosis thioredoxin C and models of intact thioredoxin system suggest new approaches to inhibitor and drug design.

Authors:  Andrew L Olson; Terrence S Neumann; Sheng Cai; Daniel S Sem
Journal:  Proteins       Date:  2013-01-15

10.  The anticancer agent chaetocin is a competitive substrate and inhibitor of thioredoxin reductase.

Authors:  Jennifer D Tibodeau; Linda M Benson; Crescent R Isham; Whyte G Owen; Keith C Bible
Journal:  Antioxid Redox Signal       Date:  2009-05       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.